Snap CEO Spiegel defends Specs as long-term bet, pushes back against activist pressure
| | | |

Snap CEO Spiegel defends Specs as long-term bet, pushes back against activist pressure

By Jaspreet Singh and Aditya Soni June 16 (Reuters) – Snap CEO Evan Spiegel told Reuters the company’s new Specs augmented-reality ā€Œglasses are part of its long-term strategy, pushing back ā€Œon activist investor demands to shut down or spin off the cash-burning unit ​behind the device. The Snapchat parent launched the device, its first consumer…

US single-family housing starts slide to eight-month low; imported inflation increases sharply
| | | |

US single-family housing starts slide to eight-month low; imported inflation increases sharply

By Lucia Mutikani WASHINGTON, June 16 (Reuters) – U.S. single-family homebuilding fell to an eight-month low in May, pressured by higher mortgage rates and building material prices, suggesting the housing market could remain a drag on economic growth in the second quarter. The decline combined with a plunge in multi-family housing starts to push down…

John Wiley & Sons, Inc. Q4 2026 Earnings Call Summary
| | | |

John Wiley & Sons, Inc. Q4 2026 Earnings Call Summary

John Wiley & Sons, Inc. Q4 2026 Earnings Call Summary – Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here. Management characterizes fiscal 2026 as a ‘breakout year’…

Elon Musk could lose nearly  trillion and still be the world’s richest person
| | | |

Elon Musk could lose nearly $1 trillion and still be the world’s richest person

Elon Musk has been the world’s richest person for a long time, but he has never seen wealth on this level. No one has. As SpaceX’s (NASDAQ: SPCX) stock price has continued to soar, so too has Musk’s net worth. And it has reached the point that Musk could lose $1 trillion and still sit…

From TASER to the Skies. Buy Axon Stock While It’s Still Down 49%
| | | |

From TASER to the Skies. Buy Axon Stock While It’s Still Down 49%

Truly great companies have an uncanny ability to evolve and expand, replicating what made them successful at one thing, and turning that into excellence at something else. Axon Enterprise (NASDAQ: AXON) made its name with TASER, a non-lethal electric weapon used by law enforcement to incapacitate suspects. Then it expanded into body cameras, dominating the…

Regret taking Social Security at 70? Here’s what to do if it haunts you (and why younger Boomers must take notice)
| | | |

Regret taking Social Security at 70? Here’s what to do if it haunts you (and why younger Boomers must take notice)

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. For some, waiting until you turn 70 is considered the smartest financial move you can make in retirement. After all, who doesn’t like a potential 24% boost (1) to monthly benefits? A study by the National Bureau of Economic…

Opinion: Trump’s Newest Trade War Threat Could Force the Fed to Act Tomorrow
| | | |

Opinion: Trump’s Newest Trade War Threat Could Force the Fed to Act Tomorrow

Quick Read Trump’s renewed tariff threats revived inflation fears just as the Iran peace deal pushed Brent crude below $80, complicating the Fed’s meeting tomorrow. Logan already warned rates may need to rise, and Reuters reports some Fed officials may project future hikes in tomorrow’s dot plot forecasts. Markets price 100% odds rates hold tomorrow,…

Gas prices edge toward  a gallon as ‘real test’ shifts to Hormuz reopening
| | | |

Gas prices edge toward $4 a gallon as ‘real test’ shifts to Hormuz reopening

Gasoline prices dropped toward the $4 per gallon threshold on Tuesday as oil futures briefly dropped below $80 for the first time since March. The national average at the pump dropped to $4.04 per gallon, according to AAA data. Prices dropped $0.13 from a week ago, and $0.47 from one month ago. At least 24…

Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
| | | |

Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?

Is RAPP a good stock to buy? We came across a bullish thesis on Rapport Therapeutics, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on RAPP. Rapport Therapeutics, Inc.’s share was trading at $38.26 as of June 15th. RAPP’s trailing P/E was 23.78 according to Yahoo Finance. Ocugen (OCGN) Reports Q1 EPS…

Is Rocket Lab Corporation (RKLB) A Good Stock To Buy Now?
| | | |

Is Rocket Lab Corporation (RKLB) A Good Stock To Buy Now?

Is RKLB a good stock to buy? We came across a bullish thesis on Rocket Lab Corporation on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on RKLB. Rocket Lab Corporation’s share was trading at $109.25 as of June 15th. Rocket Lab (RKLB) Deploys Commercial Satellite in 83rd Successful Launch Pixabay/Public Domain Rocket Lab…

End of content

End of content